Author

A. A. Tobian

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Assay:proteomics· 2 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Nardin· 2 shared A. Pekosz· 2 shared B. Abel· 2 shared E. M. Bloch· 2 shared H. Kared· 2 shared M. Fehlings· 2 shared O. Laeyendecker· 2 shared A. Casadevall· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Nardin

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Minimal cross-over between mutations associated with Omicron variant of SARS-CoV-2 and CD8+ T cell epitopes identified in COVID-19 convalescent individuals

A. Redd, A. Nardin, H. Kared, E. M. Bloch, B. Abel, A. Pekosz, O. Laeyendecker, M. Fehlings, T. Quinn, A. A. Tobian

The paper examines if CD8+ T-cell epitopes from 2020 SARS-CoV-2 convalescent individuals are mutated in the Omicron variant, finding only one epitope with a single amino acid change.

bioRxiv · Dec 6, 2021 · PreprintImmunology

CD8+ T cell responses in convalescent COVID-19 individuals target epitopes from the entireSARS-CoV-2 proteome and show kinetics of early differentiation

H. Kared, A. D. Redd, E. M. Bloch, T. S. Bonny, H. Sumatoh, F. Kairi, D. Carbajo, B. Abel, E. W. Newell, M. P. Bettinotti, S. E. Benner, E. U. Patel, K. Littlefield, O. Laeyendecker, S. Shoham, , T. C. Quinn

The paper identifies CD8+ T cell epitopes across the SARS-CoV-2 proteome in convalescent individuals and shows their differentiation kinetics and correlation with immune markers.

bioRxiv · Oct 8, 2020 · PreprintImmunology

A rapid, point of care red blood cell agglutination assay for detecting antibodies against SARS-CoV-2

R. L. Kruse, Y. Huang, H. Smetana, E. A. Gehrie, T. K. Amukele, A. A. Tobian, H. H. Mostafa, Z. Z. Wang

This paper introduces a rapid, point-of-care red blood cell agglutination assay for detecting SARS-CoV-2 antibodies using a fusion protein that binds RBCs and displays the SARS-CoV-2 RBD.

bioRxiv · May 13, 2020Pathology